ReviewExpert opinion on therapeutic targets2023

H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.

Julian S Rechberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.